Physician profile
Van Tran
NPI 1043867062
$1,329.87
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.66 · 2022: $668 · 2023: $281 · 2024: $176 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $446.82 | 2022-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $282.03 | 2022-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $190.41 | 2022-2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $140.60 | 2022-2023 | Shingrix, Bexsero |
| Sanofi Pasteur INC. | $124.99 | 2024 | |
| Merck Sharp & Dohme LLC | $49.42 | 2021-2023 | Rotateq, Vaxelis, Vaqta |
| Organon LLC | $44.24 | 2021-2024 | |
| Abbott Laboratories | $25.66 | 2025 | Mitraclip |
| Coopersurgical, INC. | $13.20 | 2023 | Paragard T 380a |
| Lundbeck LLC | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.